National HealthCare stock slipped about 3% today to US$212.72, even though the latest quarter showed profit power that long term holders will likely care more about than a single red day on the screen. Earnings per share in Q2 came in at US$2.58 on revenue of US$408.03m, backing up a trailing net profit margin of 9% and a P/E of 24x that still sits just under healthcare peers.

The headline is simple: the price is cooling in the short term while the earnings base and valuation case remain the real story over the next few years.

Like the earnings power at National HealthCare but want a wider watchlist of quality operators trading at reasonable earnings multiples? Check out 49 high quality undervalued stocks, which highlights companies that balance solid fundamentals with valuations many investors find easier to hold through volatility.

Q2 2026 Earnings Summary

• Revenue (Q2 2026 vs. Q2 2025): US$408.0m vs. US$374.9m (up about 8.8%)
• Net Income, excl. extra items (Q2 2026 vs. Q2 2025): US$40.3m vs. US$23.7m (up about 70.0%)
• Basic EPS (Q2 2026 vs. Q2 2025): US$2.58 vs. US$1.53 (up about 68.2%)
• Net Profit Margin, trailing 12 months (latest vs. prior year): 9.0% vs. 7.2% (higher margin on a trailing basis)

Prefer clear charts instead of another wall of earnings tables and ratios? Explore National HealthCare’s valuation in a full visual breakdown of the company’s financial picture in our company report for National HealthCare.

National HealthCare earnings back the defensive story

For investors leaning toward the defensive healthcare angle, National HealthCare’s recent numbers offer support. Q2 revenue of US$408.0m and net income of US$40.3m sit alongside a trailing net margin of 9%. That is consistent with a business that is holding profitability in a cost heavy sector. The unchanged US$0.67 dividend and management’s language around cash generation and balance sheet strength reinforce the idea of a stable, essential care platform rather than a highly cyclical operator.

Acquisitions and funding keep risk questions alive

The cautious view on National HealthCare is not dismissed by this quarter. The US$560m portfolio buy from National Health Investors plus the earlier US$50.5m facility purchase were funded partly with a US$475m senior unsecured term loan and a US$55m revolver. That is a clear step up in balance sheet commitments. The stock has pulled back about 3% since the latest close and is down over the past week. Investors focused on reimbursement and staffing risk now also need to weigh higher financial obligations.

Review National HealthCare’s higher debt load and recent insider selling. Then scan our risk analysis for National HealthCare which shows 1 important warning sign for any deeper structural warning signs.

Take Control of Your Next Move

If the mix of Q2 earnings strength, a 9% trailing net margin and a recent pullback in National HealthCare has your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch for a more appealing entry point. Once you are invested, keep your plan on track with the Portfolio Command Center that filters out noise and surfaces only the key developments that matter to your holdings. For longer term conviction, use the Community to see how other investors are thinking about opportunities and risks across healthcare and beyond. By spotting potential catalysts and pressure points early, you can make faster decisions and stay a step ahead of the market.

Seeking Fresh Alternatives Beyond National HealthCare

Fresh stock ideas can move from quiet to flying quickly. Use these focused lists to spot potential breakouts while they are under the radar for now. Act now.

• Target rock solid balance sheets before the crowd by scanning the curated list of solid balance sheet and fundamentals stocks (49 results), which puts resilient cash generators and cleaner financial profiles in one place.
• Ride structural energy and infrastructure momentum early by reviewing the hand picked 36 power grid technology and infrastructure stocks, built around companies tied to grid upgrades and electrification trends.
• Catch potential income workhorses while yields still look attractive with the curated 8 dividend fortresses, focused on businesses aiming to pair durability with higher payouts.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.